Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"MRP1 Substrate"”.
-
Structural and Functional Analysis of Substrate Recognition and Inhibition of the Multidrug Transporters MRP1 and MRP2
… of multidrug resistance protein 1 (MRP1), a plasma membrane ATP-binding cassette (ABC) transporter, is associated with high-risk neuroblastoma. While it is known that MRP1 transports multiple neuroblastoma chemotherapeutic agents out of the cell in a glutathione (GSH)-dependent …
-
Development of Novel Cellular Assay Model and Therapeutic Deep Eutectic Solvents to Optimize the Activity of Anticancer Agents
… activity of overexpressed ABC transporters. MRP1 is a prominent ABC transporter that pumps out a wide variety of anticancer drugs from the cells and thereby reduces intracellular drug concentrations and develops chemoresistance. Currently there are several protocols available to assess …
-
Modulation of Multidrug resistance protein 1 (MRP1) activity as a strategy to chemosensitise and radiosensitise MRP1-expressing cancers
… to treatment. Multidrug resistance protein 1 (MRP1) is a membrane transporter that is frequently overexpressed in cancer cells. By actively effluxing a wide range of chemotherapeutic agents, MRP1 can protect the cancer cell from chemotherapy. GSH is also transported by MRP1 as a low-affinity …
-
Design, Synthesis and Biological Screening of Novel Cucsinspired Estrone Analogues Towards Treatment of Hepatocellular Carcinoma
… to decrease the drug resistance by inhibiting MRP1 utilizing high-content based assay in presence of calcein-AM as MRP1 substrate. Compounds MMAmix, MMA242, MMA132, MMA335, MMA337 and MMA320 showed potential inhibitory activity on MRP1 with inhibitory activity of 70%, 63%, 46.2%, 46%, 30% and …
-
Enhancement of the cytotoxicity of MRP substrates by indomethacin and related compounds
… the MRP pump by measuring the uptake of the MRP substrate, LTC4 in to the vesicle. Surprisingly, BRI 138/1, which was quite active in the combination toxicity assay, was a weak inhibitor of LTC4 transport as compared to indomethacin and other positive indomethacin analogues suggesting, due to …